Detalles de la búsqueda
1.
Large-Scale Plasma Proteome Epitome Profiling is an Efficient Tool for the Discovery of Cancer Biomarkers.
Mol Cell Proteomics;
22(7): 100580, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37211046
2.
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.
Lancet Oncol;
22(1): 51-65, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33285097
3.
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
N Engl J Med;
379(23): 2220-2229, 2018 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30280641
4.
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.
Lancet;
394(10212): 1929-1939, 2019 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31590988
5.
Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD.
Respir Res;
20(1): 156, 2019 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31311549
6.
Comprehensive coronary plaque assessment in patients with obstructive sleep apnea.
J Sleep Res;
28(5): e12828, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30724416
7.
A suitable protocol for measuring alveolar nitric oxide in asthma with differing severity to assess peripheral airways inflammation.
J Asthma;
56(6): 584-593, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29923757
8.
Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD.
Lung;
197(2): 189-197, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30820636
9.
Association Between Serum Lipid Profile and Obstructive Respiratory Events During REM and Non-REM Sleep.
Lung;
197(4): 443-450, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30712133
10.
Human CD40 ligand-expressing type 3 innate lymphoid cells induce IL-10-producing immature transitional regulatory B cells.
J Allergy Clin Immunol;
142(1): 178-194.e11, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28939410
11.
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First-Line Nonsquamous Non-Small Cell Lung Cancer.
Oncologist;
23(6): 654-e58, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29438092
12.
Complement system activation in obstructive sleep apnea.
J Sleep Res;
27(6): e12674, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29493039
13.
Airway dynamics in COPD patients by within-breath impedance tracking: effects of continuous positive airway pressure.
Eur Respir J;
49(2)2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28202552
14.
Seasonal changes of lower respiratory tract infections in lung transplant recipients during the first post-transplant year: The Hungarian experience.
Transpl Infect Dis;
19(2)2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28164439
15.
Overnight Changes in Lung Function of Obese Patients with Obstructive Sleep Apnoea.
Lung;
195(1): 127-133, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27770204
16.
Diurnal variation of circulating microvesicles is associated with the severity of obstructive sleep apnoea.
Sleep Breath;
21(3): 595-600, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28130736
17.
TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial.
Lancet Oncol;
17(2): 212-223, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26727163
18.
Circulating periostin level in asthmatic pregnancy.
J Asthma;
53(9): 900-6, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27340880
19.
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
Lancet Oncol;
16(7): 763-74, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26045340
20.
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study.
Lancet Oncol;
16(3): 328-37, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25701171